Penicillin Salt Prices Drop To Rock Bottom
This article was originally published in PharmAsia News
Executive Summary
Penicillin industrial salt, China's number one active pharmaceutical ingredient, has seen prices slipping since last year's fourth quarter to hit almost historic lows. According to statistics, penicillin salt export dropped to only 415 metric tons last November, a record low in three years. Industry observers believe prices will continue to decline as overseas orders are put on hold on expectation of further price erosion. Meanwhile, trading companies dumping their stock and United Laboratories' penicillin salt production just coming online add pressure to an already battered market. Analysts forecast a gloomy outlook for the industry this year. (Click here for more)
You may also be interested in...
Can Organovo Leverage Its Solid Phase II Data In MASH?
Cash-limited Organovo has an FXR agonist showing competitive efficacy and tolerability in MASH, but may need a partner to move forward in that disease as it may be prioritizing its IBD program.
Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune
The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.